Cross-cultural Adaptation and Validation of the P-CIN for Chinese Pediatric Oncology Patients

Inclusion Criteria: * (1) 6 to 18 years of age * (2) were diagnosed with cancer * (3) had received or were currently receiving neurotoxic chemotherapy drugs (e.g., Vincristine, Cisplatin, Carboplatin, Oxaliplatin, Paclitaxel, Docetaxel, Ixabepilone, Bortezomib, Thalidomide) * (4) were able to communicate, read, and write in Chinese without significant hearing and vision problems to ensure they understood the P-CIN. Exclusion Criteria: * (1) had a diagnosis of cancer in the central nervous system (CNS) cancer, cancer relapse or secondary cancer * (2) in the terminal stage * (3) planned to receive multiple cancer treatment (e.g., radiotherapy and immunotherapy) * (4) suffered from other neuromuscular diseases (e.g., traumatic brain injury and cerebral palsy) * (5) had a developmental deficit (e.g., Down's syndrome and other chromosomal disorders) * (6) have suffered from psychiatric diseases or used antipsychotic drugs * (7) had peripheral neuropathy symptoms caused by diabetes, genetic diseases, spinal cord injury, or alcoholism, or * (8) had other neuromuscular disorders (e.g., traumatic brain injury, cerebral palsy).